Confidential opportunity to acquire an established, multi-location integrative and functional medicine practice serving an affluent Mid-Atlantic metropolitan market. The practice has operated for approximately two decades and has developed a recognized regional reputation for personalized, physician-led care delivered through a 100% direct-pay model. The business does not bill commercial insurance, Medicare, or Medicaid, eliminating payer-mix exposure, reimbursement delays, coding disputes, and collection risk associated with traditional medical practices.

The practice provides a broad range of recurring wellness and specialty-care programs, including hormone optimization, medical weight management, longevity and regenerative medicine, peptide protocols, intravenous therapies, chronic-condition support, cardiovascular risk reduction, sexual wellness, advanced laboratory evaluation, nutritional products, and personalized treatment planning. Patients begin with a comprehensive assessment and laboratory workup before enrolling in an appropriate annual program. Programs may be paid in a single installment or through structured payment arrangements, creating predictable revenue and strong patient continuity.

The business serves hundreds of active program participants, with most enrolled under twelve-month agreements and a high historical renewal rate. A meaningful portion of annual revenue is generated from renewals, providing an attractive base of recurring business before new-patient acquisition. Revenue is diversified across memberships, clinical services, therapies, medications, laboratory testing, diagnostics, supplements, and related products. No individual patient, program, provider, or referral source represents a material concentration of revenue.

The practice operates from several professionally appointed leased clinics and requires no owned real estate. Its asset-light structure includes office furniture, computer equipment, exam tables, specialized medical equipment, secure access systems, and other assets necessary to continue operations. The locations are supported by established third-party laboratory, pharmacy, and medical-supply relationships. The practice does not own or operate a laboratory or compounding pharmacy.

Clinical services are delivered by an experienced multi-provider team that includes physicians, an advanced-practice provider, nurses, and patient-care coordinators. A full-time general manager oversees business operations, sales, and administrative execution, reducing the founder's involvement in nonclinical activities. Key personnel are expected to support an orderly ownership transition. The lead physician is willing to remain on a reduced clinical schedule for an extended transition period, while existing management can provide operational continuity.

The practice uses an integrated electronic health record, patient portal, scheduling, enrollment, payment, and practice-management platform. New patients complete intake materials electronically, including health history, consent documentation, and payment information. The direct-pay model allows payment to be collected at enrollment or according to an approved installment schedule. Major credit cards and healthcare spending accounts are accepted, improving accessibility while maintaining favorable cash-conversion characteristics.

Annual revenue has remained near $2.9 million despite inconsistent marketing performance, regional economic softness, provider-recruiting challenges, and underperformance at a newer location. The current full-year pro forma projects approximately $2.9 million in revenue and approximately $383,000 in adjusted EBITDA after including market-rate replacement clinical compensation. A physician buyer assuming the lead clinical role may realize substantially greater owner-operator cash flow.